Brief: Hansa Bipharma Announces Directed Share Issue Of SEK 372 Mln
April 12(Reuters) - Hansa Biopharma AB HNSA.ST :
* ANNOUNCES SUCCESSFUL EXECUTION OF A DIRECTED SHARE ISSUE
OF SEK
372 MILLION (~USD 34.6 MILLION)
* BOD HAS AUTHORIZED THE ISSUE OF 12,780,000 TOTAL NEW
ORDINARY
SHARES
* PRICE FOR NEW SHARES IS SEK 29.12 PER NEW SHARE
Source text for Workspace: urn:newsml:reuters.com:*:nWkr2ZC2sS
Further company coverage: HNSA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS